IL33 and neoplasm: These results suggest that IL-33 and ST2 content in metastatic LN resembles to primary tumor and ST2 expression in the tumor epithelium (with reduced E-cadherin content) could be related to activation of a mesenchymal phenotype and potential tumor progression.